抗結(jié)核海洋放線菌的篩選及菌株HY286生物活性研究
[Abstract]:Marine actinomycetes are important sources of antituberculous drugs and their lead compounds. Using Mycobacterium smegmatis,Msm as indicator, 9 resistant actinomycetes were screened from 77 strains of actinomycetes isolated from soil of Zhangzhou shoal by plate confrontation method. One of them is an antagonistic actinomycetes HY286., which has high inhibitory effect on Msm. The colony morphology, physiological and biochemical identification and 16s r DNA sequence analysis of the strain HY286 were preliminarily identified as an actinomycetes of Madura. The MIC value, antimicrobial activity and cytotoxic activity of the fermentation product of HY286 were determined. The results showed that the MIC value of the compound produced by the strain was 200mg / L, which had a good potential for anti-Mycobacterium tuberculosis, and also had a good inhibitory effect on Bacillus subtilis and Bacillus brevis, and it had a good inhibitory effect on Bacillus subtilis and B. brevis, and had a good inhibitory effect on Bacillus subtilis and B. brevis. The inhibition rates of He La and Hep G2 were 89. 3% and 94. 2%, respectively.
【作者單位】: 陜西省微生物研究所微生物資源中心;
【基金】:陜西省科技廳項目(2016FWPT-10) 陜西省科學(xué)院科技計劃項目(2014k-35-2)
【分類號】:R915
【相似文獻】
相關(guān)期刊論文 前10條
1 吳少杰;朱麗華;楊志娟;;不同培養(yǎng)基對海洋放線菌抗微生物活性的影響[J];華北煤炭醫(yī)學(xué)院學(xué)報;2006年05期
2 蔡超靖;;海洋放線菌的研究概況[J];國外醫(yī)藥(抗生素分冊);2011年05期
3 王海雁;劉健;趙淑江;;海洋放線菌多樣性及其代謝產(chǎn)物研究進展[J];中國海洋藥物;2010年01期
4 蔡超靖;丁彥博;單越琦;穆云龍;;海洋放線菌—藥物開發(fā)的新興資源[J];國外醫(yī)藥(抗生素分冊);2012年01期
5 林親雄;劉純慧;奚濤;葉亮;邢瑩瑩;;海洋放線菌M313菌株的鑒定及其抗腫瘤活性代謝產(chǎn)物的初步研究[J];海洋科學(xué);2006年11期
6 李揚;楊依順;竇潔;王慧;楊岱琳;周長林;;一株海洋放線菌次級代謝產(chǎn)物抗真菌活性的研究[J];藥物生物技術(shù);2013年04期
7 曹國秀;陳剛;徐文峰;吳紅華;裴月湖;;海洋放線菌KSC2-1次級代謝產(chǎn)物化學(xué)成分的分離與鑒定[J];沈陽藥科大學(xué)學(xué)報;2011年12期
8 李德海,顧謙群,朱偉明,劉紅兵,方玉春,朱天驕;海洋放線菌11014中抗腫瘤活性成分的研究 I.環(huán)二肽[J];中國抗生素雜志;2005年08期
9 陸建勝;陸園園;邢瑩瑩;奚濤;;海洋放線菌WBF16次級代謝產(chǎn)物的分離與結(jié)構(gòu)鑒定[J];中國抗生素雜志;2012年04期
10 湛W歐,
本文編號:2428340
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/2428340.html